Variability within the different PON1 -omics levels was explored in a hepatometabolic patient cohort (HEPADIP cohort) to identify clinicopathological associations of PON1 regulation with predisposition to obesity-associated fatty liver disease. This evidence concerns the gene PON1 and obesity due to melanocortin 4 receptor deficiency.